Neogenomics (NEO) Other Non-Current Assets (2010 - 2026)

Neogenomics has reported Other Non-Current Assets for 16 years, with the latest figure at $9.6 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Assets rose 59.73% year-over-year to $9.6 million; the trailing twelve-month figure through Mar 2026 stood at $9.6 million (up 59.73% YoY), and the FY2025 full-year result was $9.4 million, up 59.6% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $9.6 million, up from $9.4 million in the prior quarter.
• The five-year high for Other Non-Current Assets was $9.6 million in Q1 2026, with the low at $4.1 million in Q2 2024.
• Historically, Other Non-Current Assets has averaged $6.2 million across 5 years, with a median of $5.9 million in 2024.
• Annual changes were most pronounced in 2022 — Other Non-Current Assets plunged 40.64% — and 2025, when it jumped 74.9%.
• Neogenomics' Other Non-Current Assets stood at $5.1 million in 2022, then retreated by 7.18% to $4.7 million in 2023, then grew by 24.12% to $5.9 million in 2024, then soared by 59.6% to $9.4 million in 2025, then gained by 2.14% to $9.6 million in 2026.
• The last three Other Non-Current Assets figures came in at $9.6 million (Q1 2026), $9.4 million (Q4 2025), and $8.2 million (Q3 2025), per Business Quant data.